Silo Pharma, Inc. Cash And Cash Equivalents At Carrying Value

• Silo Pharma, Inc. showed an increase of +21.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Silo Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Historical annual values: Fiscal year 2025: $4.75 million | Fiscal year 2024: $3.91 million | Fiscal year 2023: $3.52 million | Fiscal year 2022: $11.37 million | Fiscal year 2021: $9.84 million | Fiscal year 2020: $1.13 million | Fiscal year 2019: $111.8 thousand | Fiscal year 2018: $336.7 thousand | Fiscal year 2017: $294.6 thousand | Fiscal year 2016: $579.2 thousand | Fiscal year 2013: $2.01 million | Fiscal year 2012: $279.00 | Fiscal year 2011: $1.8 thousand | Fiscal year 2010: $47.5 thousand | Fiscal year 2010: $0.00.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026